✓ Koliko ima dokaza u prilog trećoj dozi?

✓ Ko bi u Srbiji trebalo da dobije buster dozu, i koje vakcine?*

— Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the primary series in:

individuals 65 years of age and older;

individuals 18 through 64 years of age at high risk of severe COVID-19; and

individuals 18 through 64 years of age whose frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19 including severe COVID-19.

Today’s authorization applies only to the Pfizer-BioNTech COVID-19 Vaccine.